Six Weeks of a NS5A Inhibitor (GS-5885), Protease Inhibitor (GS-9451) plus Peginterferon/Ribavirin (PR) Achieves High SVR4 Rates in Genotype 1 IL28B CC Treatment Naive HCV Patients: Interim Results of a Prospective, Randomized Trial Conference Proceedings uri icon

Overview

Authors

  • Authorship

    • DR Alex Thompson
    • WU X
    • FLORES N
    • PANG PS
    • ROSSI SJ
    • MCHUTCHISON JG
    • LEE SS
    • MUIR AJ
    • SHIFFMAN ML
    • ROSSARO L
    • GHALIB R
    • HAN S-HB
    • BEAVERS KL
    • PIANKO S
    • GEORGE J
    • HE L

Published in

  • Hepatology

Time

Date/time value

  • 2012

Additional Document Info

Parent Title

  • 63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD)
  • HEPATOLOGY

Volume

  • 56

Publisher

  • WB Saunders Co